APIs for Alzheimer's Disease

Alzheimer's disease is a neurodegenerative disease characterized by changes in the brain that lead to the deposition of certain proteins. Clinical manifestations include a persistent decline in memory, thought, behavior, and social skills. Commonly used APIs for the treatment of Alzheimer's disease include cholinesterase inhibitors, such as donepezil, and N-methyl-D-aspartate receptor antagonists, such as memantine hydrochloride. These compounds can help increase levels of neurotransmitters in the brain, thereby improving cognitive function and slowing the disease progression.

Protheragen-ING offers a full range of APIs for alzheimer's disease to support customer research worldwide.

Cat Product Name Cas Details Chemical Structure
API10049839 Pyritinol dihydrochloride 10049-83-9 View Details APIs
API120011703 Donepezil Hydrochloride 120011-70-3 View Details APIs
API120014064 Donepezil 120014-06-4 View Details APIs
API3685845 Meclofenoxate hydrochloride 3685-84-5 View Details APIs
Inquiry

HOURS

Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed

CONTACT US
  • Tel:
  • E-mail:
  • Address:
  • WhatsAPP
    WhatsAPP
Privacy Policy | Cookie Policy
Copyright © Protheragen-ING. All Rights Reserved.
Member of
dcat
dcat dcat dcat
Top